Amedisys Stock Analysis, Valuation (NASDAQ:AMED)

Add to My Stocks
$50.1 $0.15 (0.3%) AMED stock closing price Aug 21, 2017 (Closing)
Watch Robo Advisor Video of AMED Stock Analysis
Amedisys
Updated on : Aug 21, 2017
previous close
AMED 50.1 (0%)
S&P 500 2428.4 (0%)
Closing Price On: Aug 21, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Outpatient-Home care
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q2
$million
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
-0.2%
Operating Profit
Operating Margin:
3.6%
Sector Average:
-2.2%
5 Quarter Net Profit
Net Margins
2017-Q2
%
LTM Margin
Compared to the industry
Cash Flow
Operating cash flow:
$36.3M
Net Income:
$4.5M
PROS      CONS
Net Margins
ROIC
ROE
FCF Margin
PS Valuation
Long Term Growth
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
AMED PS :
1.1
Industry PS :
5
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
6.7%
Return on Equity:
8.6%
Free Cash Flow Margin:
8.8%
Double Tap To Exit Full Screen
0:00
/

Amedisys Analysis Video

101 5 2

View Amedisys stock analysis video. This is our AMED analyst opinion covering the buy and sell arguments for AMED stock.

Amedisys Inc Stock Rating (3.4/5)

Our Amedisys stock opinion is based on fundamentals of the company. This Amedisys stock analysis is based on latest 2017 Q2 earnings. The stock price analysis takes into account the company's valuation metrics.

Should you buy AMED stock?

  • LTM Net margins were good at 2.7% for Amedisys.
  • The lower PS ratio 1.1 for AMED stock versus Medical-Outpatient-Home care industry average of 5 is a positive for the company.
  • Amedisys generates a high return on invested capital of 6.7%.
  • Return On Equity (ROE) which is a measure of the company's profitability, looks great for Amedisys at 8.6%.
  • The company has a healthy free cash flow margin of 8.8%.

Should you sell AMED stock?

  • Revenue declined at a CAGR of -0.2% over the last 5 years.

Comments on this video and Amedisys stock